Twist Bioscience appoints Jan Johannessen to the Board of Directors and its Audit Committee

– USA, CA –  Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced the appointment of Jan Johannessen to the company’s board of directors. He will also serve as chair of the audit committee. Mr. Johannessen brings more than 25 years of executive and financial leadership experience in the semiconductor industry, including expertise in operational execution, financial controls, fundraising and international business.

“Jan brings a depth of financial acumen and operational excellence from the semiconductor industry, and his guidance will be instrumental as we grow our synthetic biology business and importantly, as we look toward the longer-term opportunity of using DNA to store digital data,” said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience.

About Jan Johannessen

Prior to Twist Bioscience, Mr. Johannessen served as CEO of Conexant Systems, LLC, a semiconductor company. Prior to his promotion to CEO of Conexant, he held the positions of chief operating officer and chief financial officer of the company. Before Conexant, Mr. Johannessen served as chief financial officer and secretary at REC Silicon Inc., one of the world’s leading renewable energy companies and a market leader in the manufacture of polysilicon and silane gasses. Previously, he served in escalating executive roles at Lattice Semiconductor Corporation, most recently as interim president and CEO. Mr. Johannessen holds a B.S. in Business from the University of Houston, and an MBA in International Business from Arizona State University.

“Twist Bioscience has already accomplished a tremendous feat in marrying silicon semiconductor technology with the commercialization and rapid scaling of the DNA synthesis platform,” commented Mr. Johannessen. “I look forward to applying my expertise in the semiconductor market and operations as the company continues to apply best principles toward evolving DNA digital data storage commercially.”

About Twist Bioscience Corporation

We are leading and rapidly growing synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of our platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. We are leveraging our unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. We are also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. We make products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

For more information :

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

Comments are closed.